MILESTONE PHARMACEUTICALS IN's ticker is MIST and the CUSIP is 59935V107. A total of 30 filers reported holding MILESTONE PHARMACEUTICALS IN in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $1,472,280 | -73.1% | 371,788 | -37.7% | 0.08% | -76.0% |
| Q3 2022 | $5,482,000 | -9.7% | 596,531 | -39.6% | 0.32% | -10.2% |
| Q2 2022 | $6,073,000 | -4.2% | 987,411 | 0.0% | 0.35% | +71.4% |
| Q1 2022 | $6,339,000 | +3.9% | 987,411 | +6.0% | 0.21% | -6.8% |
| Q4 2021 | $6,101,000 | +25.7% | 931,511 | +9.5% | 0.22% | +49.3% |
| Q3 2021 | $4,855,000 | +25.6% | 850,312 | +21.0% | 0.15% | +23.3% |
| Q2 2021 | $3,864,000 | +42.7% | 702,545 | +50.2% | 0.12% | +55.8% |
| Q1 2021 | $2,708,000 | -10.2% | 467,640 | +3.9% | 0.08% | -30.0% |
| Q4 2020 | $3,015,000 | +311.9% | 450,000 | +350.0% | 0.11% | +189.5% |
| Q3 2020 | $732,000 | – | 100,000 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ikarian Capital, LLC | 1,750,043 | $11,464,000 | 1.71% |
| Novo Holdings A/S | 2,530,585 | $16,575,000 | 0.78% |
| Boxer Capital, LLC | 2,238,861 | $14,665,000 | 0.57% |
| RTW INVESTMENTS, LP | 4,315,102 | $28,264,000 | 0.41% |
| RA Capital Management | 2,246,503 | $14,715,000 | 0.26% |
| Bleichroeder LP | 250,000 | $1,638,000 | 0.26% |
| PURA VIDA INVESTMENTS, LLC | 931,511 | $6,101,000 | 0.22% |
| Orbimed Advisors | 2,583,821 | $16,924,000 | 0.22% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 851,291 | $5,576,000 | 0.11% |
| Eversept Partners, LP | 147,165 | $963,931 | 0.06% |